Previous | Next
Part: 12 Session: 145678910111213141516171819202122 Page 931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999 of 999
Yes, indeed.
Isn't that exciting?
It is exciting. So they've gone on from leucocyte to immune.
Yes. Now, Dr. Gutterman should some time do a tape for you on his experiences with interferon, because he's the leading clinician, the biggest authority on interferon clinically, in the world at the moment. He could easily do a tape -- let's say next winter or next fall and give a summary of what the results have been.
That would be very useful I'm sure.
Very useful and very much to the point.
Well, now, Mrs. Brewer said that you were going to tell me about some of the exciting things that he was doing with immune.
Well, he is giving it to people who have, say, kidney cancer, for which there's really no good treatment.
No, it's almost a hopeless case, isn't it?
And breast cancer which has recurred. And he's had very good response with immune. And at the same time I think he's giving
© 2006 Columbia University Libraries | Oral History Research Office | Rights and Permissions | Help